Drugs / VT-122
last change Sep 2008 re-read 3 minutes ago

VT-122

Developed for
hypoproteinemia, hypercatabolic

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 2 NCT00527319 Comparator Jan 2007 → Aug 2008 hypoproteinemia, hypercatabolic Vicus Therapeutics Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as VT-122 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00527319 ↗